Prof. Dr. rer. nat. habil. Hans-Peter Deigner
Fakultät Medical and Life Sciences
Dekan
Telefon: 07720 307-4232
Fax: 07720 307-4725
Campus Villingen-Schwenningen, Raum B 2.06

Sprechzeiten: nach Vereinbarung

 

Lehrgebiete:

  • Biomarker 
  • Molekulare Diagnostik 
  • Metabolomics 
  • Biobanking 
  • Spezielle Aspekte der Systembiologie

  • Gastwissenschaftler Fraunhofer Gesellschaft, Institut für Zelltherapie und Immunologie (IZI), EXIM, Rostock
  • Gründungsmitglied und Mitglied des Exekutivkomitees der Europäischen Gesellschaft für Biopreservation und Biobanking (ESBB, www.esbb.org

Publikationen

Hans-Peter Deigner

2017 | 2016 | 2015 | 2012 | 2011 | 2010 | 2009

2017

Kanan Wahedy, Bassam Abu Thaher, Dieter Schollmeyer, Ihab Almasri, Rami Morjan, Basem Qeshta, Hans-Peter Deigner Crystal structures of pure 3-(4-bromo-2-chlorophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one
Hans-Peter Deigner, Matthias Kohl, Christoph Ruppert, Sowmya S. Perumbakkam, Lisa Jacob, Anika Schmidt Diagnostische Schnelltests für die personalisierte Medizin
Markus Bläss, Nelly Bibak, Ralf A. Claus, Matthias Kohl, Gabriel A. Bonaterra, Ralf Kinscherf, Stefan Laufer, Hans-Peter Deigner NB 06: From a simple lysosomotropic aSMase inhibitor to tools for elucidating the role of lysosomes in signaling apoptosis and LPS-induced inflammation

2016

Ha-Yeun Chung, Daniel C. Hupe, Gordon P. Otto, Marcel Sprenger, Alexander C. Bunck, Michael J. Dorer, Clemens L. Bockmeyer, Hans-Peter Deigner, Markus H. Gräler, Ralf A. Claus Acid Sphingomyelinase Promotes Endothelial Stress Response in Systemic Inflammation and Sepsis
Hans-Peter Deigner Bimodal imaging and beyond: Editorial
Basri Gülbakan, Riza Köksal Özgül, Ayse Yüzbasioglu, Matthias Kohl, Hans-Peter Deigner, Meral Özgüc Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine
Mario Brameshuber, Eva Sevcsik, Benedikt K. Rossboth, Christina Manner, Hans-Peter Deigner, Begüm Peksel, Mária Péter, Zsolt Török, Albin Hermetter, Gerhard J. Schütz Oxidized Phospholipids Inhibit the Formation of Cholesterol-Dependent Plasma Membrane Nanoplatforms

2015

Mostafa Mahmoud, Hans-Peter Deigner Aptamers in Diagnostics: Replacing or Complementing Antibodies?
Markus Bläss, Ralf A. Claus, Hans-Peter Deigner HPLC separation and ultrasensitive optical quantification of ceramide species applying 7-(diethylamino)coumarin-3-carbonyl azide derivatisation
Christoph Ruppert, Matthias Kohl, Lisa Jacob, Hans-Peter Deigner Multiplexing in Bioassays
Markus Bläss, H.P. Le, Ralf A. Claus, Matthias Kohl, Hans-Peter Deigner Stereospecific Induction of Apoptosis in Tumor Cells via Endogenous C16-Ceramide and Distinct Transcripts

2012

Martina Weber, Sandro Lambeck, Nadine Ding, Stefanie Henken, Matthias Kohl, Hans-Peter Deigner, David P. Enot, Ignatius E. Igwe, Lucien Frappart, Michael Kiehntopf, Ralf A. Claus, Thomas Kamradt, Debra Weih, Yoram Vodovotz, David E. Briles, Abiodun D. Ogunniyi, James C. Paton, Ulrich A. Maus, Michael Bauer Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia

2011

Matthias Kohl, S. Koch, M. Keller, Hans-Peter Deigner Bright Future in Clinical Dx?
Hans-Peter Deigner, Michael Bauer, Matthias Kohl Method for in vitro diagnosing sepsis utilizing biomarker composed of more than two different types of endogenous biomolecules
Hans-Peter Deigner, Matthias Kohl, Therese Koal, Ignatius E. Igwe, Guido Dallmann, Michael Bauer, David Enot Use of bile acids for prediction of an onset of sepsis

2010

Julien B. Landré, Markus Bläss, Matthias Kohl, Tina Schlicksbier, Andriy Ruryk, Ralf Kinscherf, Ralf A. Claus, Albin Hermetter, Matthias Keller, Michael Bauer, Hans-Peter Deigner Addressable bipartite molecular hook (ABMH): Immobilized hairpin probes with sensitivity below 50 fM
Hans-Peter Deigner, Matthias Kohl, Matthias Keller, Therese Koal, Klaus Weinberger Method for In Vitro Diagnosing a Complex Disease
Hans-Peter Deigner, Matthias Kohl, David Enot, Therese Koal, Matthias Keller Method for Predicting the Likelihood of an Onset of an Inflammation Associated Organ Failure
Hans-Peter Deigner, Matthias Kohl, Matthias Keller, Therese Koal Method for normalization in metabolomics analysis methods with endogenous reference metabolites
Matthias Keller, Hans-Peter Deigner, David Enot, Matthias Kohl, Ronnaug Solberg, Didirik O. Saugstad, Therese Koal Method of Diagnosing Asphyxia
Matthias Kohl, Hans-Peter Deigner Preprocessing of gene expression data by optimally robust estimators.
William J. Griffiths, Therese Koal, Yuqin Wang, Matthias Kohl, David P. Enot, Hans-Peter Deigner Targeted Metabolomics for Biomarker Discovery
Hans-Peter Deigner, David Enot, Matthias Kohl, Ignatius E. Igwe, Therese Koal, Michael Bauer, Guido Dallmann Use of Endogenous Metabolites for Early Diagnosing Sepsis

2009

Johannes Winning, Julia Reichel, Yvonne Eisenhut, Jürg Hamacher, Matthias Kohl, Hans-Peter Deigner, Ralf A. Claus, Michael Bauer, Wolfgang Lösche Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms
Hans-Peter Deigner, Matthias Kohl The molecular sepsis signature